Last reviewed · How we verify
NCT02755376
Development of Novel Strategy for Treatment of Anterior Cruciate Ligament (ACL) Injury Using Stem Cell
NA trial testing Cartistem(TM) in Deficiency of Anterior Cruciate Ligament in 30 participants. Completed in 1 December 2018.
28 April 2016
Quick facts
| Lead sponsor | Samsung Medical Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 1 January 2014 |
| Primary completion | 28 April 2016 |
| Estimated completion | 1 December 2018 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- Cartistem(TM) — full drug profile →
- hyaluronic acid (HYALURONIC ACID) — full drug profile →
- ACL reconstruction only
Conditions studied
- Deficiency of Anterior Cruciate Ligament — all drugs for Deficiency of Anterior Cruciate Ligament →
Sponsor
Samsung Medical Center
Who can join
Adults 20 to 50, any sex, with Deficiency of Anterior Cruciate Ligament. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Purpose:Development of novel strategy for treatment of anterior cruciate ligament (ACL) injury using stem cell.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Engineering Stem and Stromal Cell Therapies for Musculoskeletal Tissue Repair.
Loebel C, Burdick JA. · · 2018 · cited 105× · PMID 29429944 · DOI 10.1016/j.stem.2018.01.014 -
Umbilical cord mesenchymal stromal cells-from bench to bedside.
Chetty S, Yarani R, Swaminathan G, Primavera R, et al · · 2022 · cited 25× · PMID 36313578 · DOI 10.3389/fcell.2022.1006295 -
An overview of stem cells and cell products involved in trauma injury.
Saeedi P, Nilchiani LS, Zand B, Hajimirghasemi M, et al · · 2025 · cited 1× · PMID 40143930 · DOI 10.1016/j.reth.2025.02.011
Verify or expand the search:
- PubMed search for NCT02755376
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Samsung Medical Center trials
Trials by the same sponsor.
- NCT07482865 — Routine Versus Provisional Distal Perfusion Catheter Placement in Patients Undergoing Mechanical Circulatory Support · NA · not yet recruiting
- NCT07467213 — Routine Use of Potassium Competitive Acid Blocker vs. Guideline-Directed Gastrointestinal Protection Strategy in Acute M · Phase 4 · not yet recruiting
- NCT07530913 — Effectiveness Analysis of a Rehabilitation Exercise Platform for Living Donor Liver Transplantation Patients · NA · enrolling by invitation
- NCT07500701 — Salvage Moderate Hypofractionated Versus Ultrahypofractionated Radiotherapy for Biochemical Recurrence After Radical Pro · Phase 3 · recruiting
- NCT07409441 — Korea Acute Myocardial Infarction Registry · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02755376 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Samsung Medical Center
- Last refreshed: 10 April 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02755376.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing